
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6424695
[patent_doc_number] => 20100168085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells'
[patent_app_type] => utility
[patent_app_number] => 10/557901
[patent_app_country] => US
[patent_app_date] => 2004-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19191
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557901
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557901 | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells | May 22, 2004 | Abandoned |
Array
(
[id] => 5034724
[patent_doc_number] => 20070099263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Materials and methods relating to g-protein coupled receptor oligomers'
[patent_app_type] => utility
[patent_app_number] => 10/555709
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17770
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099263.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555709 | Materials and methods relating to G-protein coupled receptor oligomers | May 17, 2004 | Issued |
Array
(
[id] => 4982441
[patent_doc_number] => 20070086999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Compositions and methods including a recombinant human mab that promotes cns remyelination'
[patent_app_type] => utility
[patent_app_number] => 10/557115
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19878
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20070086999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557115
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557115 | Compositions and methods including a recombinant human MAB that promotes CNS remyelination | May 16, 2004 | Issued |
Array
(
[id] => 7144020
[patent_doc_number] => 20050118677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection'
[patent_app_type] => utility
[patent_app_number] => 10/846185
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10846185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/846185 | CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection | May 13, 2004 | Issued |
Array
(
[id] => 4706671
[patent_doc_number] => 20080066195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Taste Receptors of the T1r Family Form Domestic Cat'
[patent_app_type] => utility
[patent_app_number] => 10/591360
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28541
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20080066195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591360 | Taste receptors of the T1R family from domestic cat | May 12, 2004 | Issued |
Array
(
[id] => 216938
[patent_doc_number] => 07611848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Method for selecting allosteric regulators of class III G protein-coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 10/557986
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6875
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/611/07611848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557986
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557986 | Method for selecting allosteric regulators of class III G protein-coupled receptors | May 10, 2004 | Issued |
Array
(
[id] => 7045518
[patent_doc_number] => 20050250113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Mammalian magnesium/manganese sensing G protein coupled receptor'
[patent_app_type] => utility
[patent_app_number] => 10/841129
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18615
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841129 | Mammalian magnesium/manganese sensing G protein coupled receptor | May 6, 2004 | Abandoned |
Array
(
[id] => 7154238
[patent_doc_number] => 20050026224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Methods and compositions for modulating G-protein coupled receptor 54'
[patent_app_type] => utility
[patent_app_number] => 10/833829
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19620
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833829 | Methods and compositions for modulating G-protein coupled receptor 54 | Apr 27, 2004 | Abandoned |
Array
(
[id] => 468115
[patent_doc_number] => 07232567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-19
[patent_title] => 'Anti-CCR1 antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/832985
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 19926
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/232/07232567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832985 | Anti-CCR1 antibodies and methods of use thereof | Apr 25, 2004 | Issued |
Array
(
[id] => 5216023
[patent_doc_number] => 20070105104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)'
[patent_app_type] => utility
[patent_app_number] => 10/555771
[patent_app_country] => US
[patent_app_date] => 2004-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34017
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555771 | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) | Apr 23, 2004 | Abandoned |
Array
(
[id] => 7203194
[patent_doc_number] => 20050042720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Novel promiscuous G alpha protein mutants and their use'
[patent_app_type] => utility
[patent_app_number] => 10/830716
[patent_app_country] => US
[patent_app_date] => 2004-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11148
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830716 | Novel promiscuous G alpha protein mutants and their use | Apr 23, 2004 | Abandoned |
Array
(
[id] => 322429
[patent_doc_number] => 07517661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Methods of screening for ligands for FPRL2'
[patent_app_type] => utility
[patent_app_number] => 10/554234
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 43816
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554234 | Methods of screening for ligands for FPRL2 | Apr 21, 2004 | Issued |
Array
(
[id] => 4650991
[patent_doc_number] => 20080038247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)'
[patent_app_type] => utility
[patent_app_number] => 10/555428
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34509
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555428 | Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) | Apr 21, 2004 | Abandoned |
Array
(
[id] => 7441565
[patent_doc_number] => 20040185533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Corticotropin-releasing factor2 receptors'
[patent_app_type] => new
[patent_app_number] => 10/821502
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26128
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821502 | Corticotropin-releasing factor2 receptors | Apr 8, 2004 | Issued |
Array
(
[id] => 6966486
[patent_doc_number] => 20050233383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Human olfactory receptors and genes encoding same'
[patent_app_type] => utility
[patent_app_number] => 10/819316
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 42952
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10819316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/819316 | Human olfactory receptors and genes encoding same | Apr 6, 2004 | Abandoned |
Array
(
[id] => 7421611
[patent_doc_number] => 20040229217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Screening process for various indications using BNPI and/or DNPI'
[patent_app_type] => new
[patent_app_number] => 10/807500
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 20732
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229217.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807500 | Screening process for various indications using BNPI and/or DNPI | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7183321
[patent_doc_number] => 20040203080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => '7 transmembrane receptor family member BLRx'
[patent_app_type] => new
[patent_app_number] => 10/804289
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23091
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804289 | 7 transmembrane receptor family member BLRx | Mar 18, 2004 | Abandoned |
Array
(
[id] => 4827148
[patent_doc_number] => 20080125491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Cell Death-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 10/549228
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 109100
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549228 | Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders | Mar 14, 2004 | Issued |
Array
(
[id] => 797901
[patent_doc_number] => 07427487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 10/548898
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17474
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548898 | Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders | Mar 14, 2004 | Issued |
Array
(
[id] => 6952144
[patent_doc_number] => 20050227238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74'
[patent_app_type] => utility
[patent_app_number] => 10/800249
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 116321
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800249 | Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 | Mar 11, 2004 | Issued |